SCHMERTZLER MICHAEL bought PTCT
January 2, 2026 · Form 4 insider transaction
SCHMERTZLER MICHAEL bought 6,950 shares of PTC Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
6,950
Price
$0.00
Total value
N/A
InsiderSCHMERTZLER MICHAEL
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 2, 2026
Filing dateJanuary 6, 2026
Shares owned after6,950
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option was granted on January 2, 2026 and vests over one year in twelve equal monthly installments, commencing on February 2, 2026.